PBYI - Puma Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
280,379
250,991
27,685
0
0
Cost of Revenue
37,059
34,621
5,572
-
0
Gross Profit
243,320
216,370
22,113
-
0
Operating Expenses
Research Development
140,925
164,854
207,810
222,798
208,472
Selling General and Administrative
151,349
146,188
106,693
53,798
31,808
Total Operating Expenses
292,274
311,042
314,503
276,596
240,280
Operating Income or Loss
-48,954
-94,672
-292,390
-276,596
-240,280
Interest Expense
15,720
10,985
720
-
-
Total Other Income/Expenses Net
-33,524
-9,714
-101
-373
25
Income Before Tax
-95,095
-113,575
-291,955
-276,011
-239,284
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-95,095
-113,575
-291,955
-276,011
-239,284
Net Income
-95,095
-113,575
-291,955
-276,011
-239,284
Net Income available to common shareholders
-95,095
-113,575
-291,955
-276,011
-239,284
Reported EPS
Basic
-
-2.99
-7.85
-8.29
-7.45
Diluted
-
-2.99
-7.85
-8.29
-7.45
Weighted average shares outstanding
Basic
-
37,942
37,170
33,295
32,126
Diluted
-
37,942
37,170
33,295
32,126
EBITDA
-
-95,206
-288,424
-275,447
-239,504